ICU Medical

ICU Medical EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ICU Medical (ICUI) as of Oct 20, 2026 is 108.55 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 44.12 M USD — a change of 146.02% (higher).

EBITDA

108.55 MUSD

YoY

146.02%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ICU Medical is 2025 108.55 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ICU Medical was 2024 44.12 M USD. It decreases by 146.02% higher compared to the previous year.

The ICU Medical EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
30.47 M USD
Jan 1, 2019
107.91 M USD
Jan 1, 2020
98.56 M USD
Jan 1, 2021
123.85 M USD
Jan 1, 2022
-42.20 M USD
Jan 1, 2023
23.86 M USD
Jan 1, 2024
44.12 M USD
Jan 1, 2025
108.55 M USD
The ICU Medical EBITDA history
YEAREBITDAYoY
108.55 MUSD+146.02%
44.12 MUSD+84.92%
23.86 MUSD-156.54%
-42.20 MUSD-134.07%
123.85 MUSD+25.65%
98.56 MUSD-8.66%
107.91 MUSD+254.21%
30.47 MUSD-42.87%
53.33 MUSD-35.70%
82.94 MUSD+20.97%
68.57 MUSD+75.64%
39.04 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

ICU Medical Stock analysis

What does ICU Medical do? ICU Medical Inc is a US medical technology company specializing in the development and production of innovative products for infusion and oncology therapy. It was founded in 1984 by Dr. George A. Lopez and has become a leading manufacturer of disposable products for infusion therapy. The company offers a wide range of disposable products for infusion and oncology therapy, including solutions, medication administration systems, catheters, syringes, tubes, and sensors. They also manufacture medical devices such as syringe pumps, medication administration pumps, and gravity infusion devices. ICU Medical Inc collaborates with other companies in the medical and pharmaceutical industries to provide comprehensive solutions for intravenous therapy. The company's product range includes syringes, tubes, catheters, combination products, infusion and syringe pumps, and the Clave technology for closed infusion pump systems. ICU Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ICU Medical stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ICU Medical is 108.55 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ICU Medical changed from 44.12 M USD to 108.55 M USD, representing a 146.02% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) ICU Medical since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s ICU Medical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — ICU Medical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — ICU Medical